Mayo Clinic released a new DNA product with Helix, a personal genomics company, called "Mayo Clinic GeneGuide." The DNA-powered product provides healthy individuals with genetic testing and insights with a focus on education.
Week in Review: October 4 - Insights
Top highlights include: Flu vaccine information, possible effects that red meat has on the human body, and what vaping does to the lungs.
Week in Review: October 18 - Insights
Top highlights include: scientists continue to investigate mysterious vaping illnesses, a possible vaccine for breast cancer could be available in less than a decade, and determining if patients are sick from the flu or from vaping.
Week in Review: October 11 - Insights
Top highlights include: Discussions around flu season, teen vaping, spotting signs of cognitive impairment, and DNA tests.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights
This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Serologic testing for celiac disease in patients with IgA deficiency - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses serologic testing for Celiac Disease in patients with IgA deficiency.
November 2023 - Laboratory Genetics and Genomics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.
October 2023 - Coagulation - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Coagulation.
Mayo Clinic Researchers Find New Way to Improve Newborn Screening of Pompe Disease - Insights
Researchers at Mayo Clinic have discovered a second-tier test for Pompe disease that has been shown to improve the specificity of newborn screening for the disorder, which would lower the rate of false-positive results.